منابع مشابه
Pregnancy and isotretinoin therapy.
Moreover, this ratio has increased to one-third for drugs given a priority review. Because we do have specific evidence for interactions between some medications and grapefruit, the public should be updated about new drugs where this interaction may be missed. Is it sufficient that we identify these warnings and withdrawals only after they may have caused human suffering? After 20 years and hun...
متن کاملIsotretinoin and Psychiatric Effects
Isotretinoin is a vitamin A derivative that has been commonly used by dermatologists for the treatment of acne. Isotretinoin has many dose-related side-effects, which have caused many debates lately, especially related to psychiatric and gastrointestinal issues. Since the introduction of isotretinoin into the market, there have been a growing number of reported cases of psychiatric side-effects...
متن کاملIsotretinoin and Inflammatory Bowel Disease
included gastric antral vascular ectasia (GAVE) (6), GAVE and AD (6), tumor (9), polyps (2), Crohn’s disease (3), NSAID ulceration (3), peptic ulcer disease (3), varices (2), small bowel ulcers (4), Dieulafoy (1), and miscellaneous (11). Carey described advanced age as the only predictive factor in overt OGB. However, in our data set (using multivariate analysis), both transfusion dependence (P...
متن کاملProgesterone and FOXO1 signaling
Cancer recurrence is associated with treatment failure and is the main cause of death, 1 and thus remains to be a major clinical challenge. elevated level of the cyclin-dependent kinase 1 (CDK1) correlates with cancer recurrence and treatment resistance in patients with breast cancer or colorectal cancer. 2,3 it is proposed that defects in CDKs may lead to the accumulated genetic defects, which...
متن کاملImproving bioavailability with a novel isotretinoin formulation (isotretinoin-Lidose).
Current practice guidelines recommend administration of oral isotretinoin with high-fat meals, which may pose issues with patient compliance. Isotretinoin-Lidose (Epuris™), approved by Health Canada in November 2012 and scheduled for commercial release June 2013, is based on novel lipid encapsulation technology (Lidose®) to enclose isotretinoin, thereby increasing drug absorption during fasted ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Dermato-Endocrinology
سال: 2011
ISSN: 1938-1980
DOI: 10.4161/derm.15331